ALPHA, also known as 3,4-methylenedioxy-α-ethylbenzylamine, is a psychoactive drug of the substituted benzylamine group and a positional isomer of 3,4-methylenedioxyamphetamine (MDA).[1][2] It is also a benzylamine analogue of 3,4-methylenedioxyamphetamine (MDA).[1][2] ALPHA was first synthesized by Alexander Shulgin.[1][2] In his book PIHKAL on the MDA page, the threshold dosage is listed as 10 mg.[1] At mild threshold dosages (around 10 mg) there are eyes-closed "dreams" with some body tingling, at higher doses (up to 140 mg) was reported to produce a pleasant, positive feeling.[1] This compound is not anoretic at any dose.[1] Its duration is about 3 hours.[1] Very little data exists about the pharmacological properties, metabolism, and toxicity of ALPHA.[1][2] The drug was encountered as a novel designer drug by 1996.[3][4]

See also

References

  1. 1 2 3 4 5 6 7 8 9 10 11 MDA Entry in PIHKAL
  2. 1 2 3 4 Shulgin A, Manning T, Daley PF (2011). The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds. Vol. 1. Berkeley: Transform Press. ISBN 978-0-9630096-3-0.
  3. ↑ King L, Poortman-van der Meer A, Huizer H (1996). "1-Phenylethylamines: a new series of illicit drugs?". Forensic Science International. 77 (3): 141–149. doi:10.1016/0379-0738(95)01852-2. PMID 8819989. Retrieved 9 April 2025.
  4. ↑ King LA (1996). "Designer drugs related to amphetamine (1990-1996)". Journal of the Clandestine Laboratory Investigating Chemists Association. 6 (3): 15–16.
source: https://en.wikipedia.org/wiki/ALPHA_(drug)